Glaukos (GKOS) Non-Current Deferred Tax Liability (2019 - 2026)
Glaukos (GKOS) posted quarterly Non-Current Deferred Tax Liability of $441000.0 for Q2 2026, down 93.62% year-over-year from $6.9 million in Q2 2025, and little changed quarter-over-quarter from $441000.0 in Q1 2026.
Glaukos (GKOS) Non-Current Deferred Tax Liability (2019 - 2026) Analysis & Trends
Glaukos (GKOS) has reported Non-Current Deferred Tax Liability for 8 consecutive years, with $441000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Non-Current Deferred Tax Liability fell 93.62% year-over-year to $441000.0; the TTM figure through Jun 2026 stood at $441000.0 (down 93.62% YoY), while the FY2025 annual figure was $441000.0, down 93.63% from the prior year.
- Non-Current Deferred Tax Liability held at $441000.0 in Q2 2026 per GKOS's latest filing, from $441000.0 in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $7.3 million in Q1 2022 and bottomed at $441000.0 in Q4 2025.
- Historically, Non-Current Deferred Tax Liability has averaged $6.0 million across 5 years, with a median of $7.1 million in 2023.
- Annual changes were most pronounced in 2023 — Non-Current Deferred Tax Liability declined 0.67% — and 2025, when it plunged 93.63%.
- Glaukos' Non-Current Deferred Tax Liability stood at $7.3 million in 2022, then slipped by 1.65% to $7.1 million in 2023, then decreased by 3.02% to $6.9 million in 2024, then slumped by 93.63% to $441000.0 in 2025, then changed by 0.0% to $441000.0 in 2026.
- Business Quant data shows GKOS's Non-Current Deferred Tax Liability at $441000.0 in Q2 2026, $441000.0 in Q1 2026, and $441000.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn |
| 10 | Glaukos | 11.08 Bn | 10.96 Bn | 151.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 441,000.00 |
| Jun 30, 2026 | 441,000.00 |
| Mar 31, 2026 | 441,000.00 |
| Mar 31, 2026 | 441,000.00 |
| Dec 31, 2025 | 441,000.00 |
| Dec 31, 2025 | 441,000.00 |
| Sep 30, 2025 | 6.92 Mn |
| Sep 30, 2025 | 6.92 Mn |
| Jun 30, 2025 | 6.91 Mn |
| Jun 30, 2025 | 6.91 Mn |
| Mar 31, 2025 | 6.92 Mn |
| Mar 31, 2025 | 6.92 Mn |
| Dec 31, 2024 | 6.93 Mn |
| Dec 31, 2024 | 6.93 Mn |
| Sep 30, 2024 | 7.14 Mn |
| Sep 30, 2024 | 7.14 Mn |
| Jun 30, 2024 | 7.14 Mn |
| Jun 30, 2024 | 7.14 Mn |
| Mar 31, 2024 | 7.14 Mn |
| Mar 31, 2024 | 7.14 Mn |